Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 3
2006 3
2007 4
2008 4
2009 4
2010 6
2011 7
2012 12
2013 7
2014 6
2015 11
2016 10
2017 14
2018 13
2019 11
2020 24
2021 27
2022 15
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Immune persistence after pertussis vaccination.
Chen Z, He Q. Chen Z, et al. Among authors: he q. Hum Vaccin Immunother. 2017 Apr 3;13(4):744-756. doi: 10.1080/21645515.2016.1259780. Epub 2017 Jan 3. Hum Vaccin Immunother. 2017. PMID: 28045580 Free PMC article. Review.
Molecular Epidemiology of Bordetella pertussis.
Barkoff AM, He Q. Barkoff AM, et al. Among authors: he q. Adv Exp Med Biol. 2019;1183:19-33. doi: 10.1007/5584_2019_402. Adv Exp Med Biol. 2019. PMID: 31342459 Review.
Evolution of Bordetella pertussis.
He Q. He Q. Pediatr Infect Dis J. 2016 Aug;35(8):915-7. doi: 10.1097/INF.0000000000001218. Pediatr Infect Dis J. 2016. PMID: 27213264 Review. No abstract available.
PERISCOPE: road towards effective control of pertussis.
PERISCOPE Consortium. PERISCOPE Consortium. Lancet Infect Dis. 2019 May;19(5):e179-e186. doi: 10.1016/S1473-3099(18)30646-7. Epub 2018 Nov 28. Lancet Infect Dis. 2019. PMID: 30503084 Review.
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
Keech C, Miller VE, Rizzardi B, Hoyle C, Pryor MJ, Ferrand J, Solovay K, Thalen M, Noviello S, Goldstein P, Gorringe A, Cavell B, He Q, Barkoff AM, Rubin K, Locht C. Keech C, et al. Among authors: he q. Lancet. 2023 Mar 11;401(10379):843-855. doi: 10.1016/S0140-6736(22)02644-7. Lancet. 2023. PMID: 36906345 Clinical Trial.
Factors contributing to pertussis resurgence.
He Q, Mertsola J. He Q, et al. Future Microbiol. 2008 Jun;3(3):329-39. doi: 10.2217/17460913.3.3.329. Future Microbiol. 2008. PMID: 18505398 Review.
180 results